The quarter broadly met the operating bar, while adjusted EPS came in ahead. Published estimates called for roughly $474.5 million of revenue and $1.73 of adjusted EPS; ICF delivered $474.5 million and $1.86, respectively. The revenue result was effectively on consensus, so the main beat was earnings rather than demand acceleration.
| Metric | Q2 2026 | Q2 2025 / expectation |
|---|---|---|
| Revenue | $474.5M | $476.2M prior year; ~$474.5M consensus |
| GAAP diluted EPS | $1.49 | $1.28 prior year |
| Non-GAAP diluted EPS | $1.86 | $1.66 prior year; ~$1.73 consensus |
| Adjusted EBITDA | $53.4M | $52.9M prior year |
| Adjusted EBITDA margin | 11.2% | 11.1% prior year |
| Contract awards | $402M | 0.85 quarterly book-to-bill |
| Business-development pipeline | $9.3B | Up 9% sequentially |
| Full-year revenue guidance | $1.89B–$1.96B | Reaffirmed |
| Full-year non-GAAP EPS guidance | $6.95–$7.25 | Reaffirmed |
The EPS beat was helped materially by a lower tax rate, not a major operating inflection. GAAP EPS rose to $1.49 from $1.28, but the tax rate fell to 17.8% from 21.0%; adjusted EBITDA was only modestly higher and operating income was essentially flat at $39.9 million versus $40.0 million. That makes the headline earnings upside less powerful than the 12% adjusted-EPS growth suggests. (Financial Results; Reconciliation of Non-GAAP Financial Measures)
The business mix is improving, but federal weakness remains the central offset. Commercial revenue grew 5.9%, international government revenue jumped 35.1%, and federal revenue improved 1.4% sequentially—but federal revenue was still down 9.5% year over year, while state and local revenue declined 1.9%. The mix shifted toward commercial and international work, which helped margins, but the expected federal recovery is still mostly a second-half promise. (Commercial Revenue Highlights; Government Revenue Highlights)
The pipeline is encouraging, but near-term bookings were not strong enough to signal a clean acceleration. The pipeline reached $9.3 billion, up 9% sequentially, and ICF said it had won more than $200 million of awards after quarter-end. However, Q2 contract awards of $402 million produced a 0.85 book-to-bill ratio, below replacement value for the quarter; the trailing-twelve-month ratio of 1.09 is healthier. (Backlog and New Business; Management Commentary)
Net, this is a modest upside surprise rather than a changed growth story. ICF reaffirmed its full-year ranges, supported by roughly 90% of midpoint revenue already in backlog, and maintained the $0.14 quarterly dividend while repurchasing 217,542 shares in Q2. The result is slightly better than expectations because of the adjusted-EPS beat and stronger pipeline, but the in-line revenue, tax-aided earnings lift, federal revenue decline, and sub-1.0 quarterly book-to-bill keep the read from being strongly positive. (Summary and Outlook; Dividend Declaration; Cash Flow statement)
Read the original 8-K on SEC EDGAR ↗